Effect of percutaneous transluminal coronary angioplasty on coronary reserve
This study was done to assess the effect of percutaneous transluminal coronary angioplasty (PTCA) on regional myocardial perfusion (RMP) in the region distal to a stenosis in 48 patients. Quantitative RMP in ml/100g/min was measured from the washout of Xe-133 following selective injection into the involved coronary artery. After successful dilation, determined by a reduction in %stenosis to a less than or equal to 50% lesion and in pressure gradient across the lesion, the RMP measurement was repeated. In these patients, means %stenosis was 85% pre PTCA and 29% post PTCA with mean pressure gradient of 60 Hg pre PTCA and 21 mm Hg post PTCA. 21 of these 48 patients also had RMP measured after isoproterenol (ISO) both pre and post PTCA to increase myocardial oxygen demand to assess coronary reserve. Heart rate (HR) and systolic blood pressure (SBP) were constant pre and post PTCA which allowed a valid comparison. The results are presented. A group of 13 patients with normal coronary arteries and ventricular function showed a mean control RMP of 78 +- 15 and a mean ISO RMP of 140 +- 26. The data demonstrate that following successful PTCA quantitative RMP improves both at rest and with an ISO challenge and is similar to RMP in normal coronary arteries.
- Research Organization:
- Univ. of Wisconsin Medical School, Mount Sinai Medical Center, Milwaukee, WI
- OSTI ID:
- 6476329
- Report Number(s):
- CONF-840619-; TRN: 87-022248
- Journal Information:
- J. Nucl. Med.; (United States), Vol. 25:5; Conference: 31. annual meeting of the Society of Nuclear Medicine, Los Angeles, CA, USA, 5 Jun 1984
- Country of Publication:
- United States
- Language:
- English
Similar Records
Comparison of the angiographic and scintigraphic evaluation of the success of percutaneous transluminal coronary angioplasty
Prognostic value of computer-quantitated exercise thallium imaging early after percutaneous transluminal coronary angioplasty
Related Subjects
CARDIOVASCULAR AGENTS
PERFORMANCE
UPTAKE
HEART
BLOOD FLOW
DYNAMIC FUNCTION STUDIES
MYOCARDIUM
ANTIHYPERTENSIVE AGENTS
BIOCHEMICAL OXYGEN DEMAND
BLOOD PRESSURE
COMPARATIVE EVALUATIONS
CORONARIES
PATIENTS
RADIOPHARMACEUTICALS
RADIOTHERAPY
RETENTION FUNCTIONS
SURGERY
THERAPY
TISSUE DISTRIBUTION
VASODILATION
XENON 133
ARTERIES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BLOOD VESSELS
BODY
CARDIOVASCULAR SYSTEM
DAYS LIVING RADIOISOTOPES
DISTRIBUTION
DRUGS
EVEN-ODD NUCLEI
FUNCTIONS
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MEDICINE
MUSCLES
NUCLEAR MEDICINE
NUCLEI
ORGANS
RADIOISOTOPES
RADIOLOGY
XENON ISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics